December 10 @2:00-3:30pm ET
Panel II - How Personalized Medicine Can Influence Healthcare Reform, Politics and Health Economics
- How will policy and reforms limit innovation?
- Balancing access and cost
- How can industry fulfill the healthcare promise?
- Why is it taking so long? What does it take to get it going and to be of value to the healthcare system?
- What are the issues in operations, administration and delivery of personalized medicine in our current healthcare system and what needs to be done to successfully implement personalized medicine?
- How can one develop personalized medicine without bankrupting the system?
- Cost-benefit analysis on drug-diagnostic co-development - understanding the economics and its implications
Moderator:
Joseph V. Ferrara, President, Boston Healthcare Associates
Panel Participants:
Elizabeth Mansfield, Ph.D., Director, Personalized Medicine Staff, OIVD/CDRH, FDA
Wayne Rosenkrans, Ph.D., Chairman & President, Personalized Medicine Coalition
Giora Feuerstein, M.D., Assistant Vice President, Head of Discovery Translational Medicine, Wyeth Research
Bruce Quinn, MD, Ph.D., Senior Health Policy Specialist, Foley Hoag LLP
Sharon Terry, President & CEO, Genetic Alliance
Patrick Terry, Ph.D., President & CEO, Technic Solutions, LLC.
